Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation

Glucagon-like peptide 1 (GLP-1) is object of intensive investigation for not only its metabolic effects but also the protective vascular actions. Since platelets exert a primary role in the pathogenesis of atherosclerosis, inflammation and vascular complications, we investigated whether GLP-1 direct...

Descripción completa

Detalles Bibliográficos
Autores principales: Barale, Cristina, Buracco, Simona, Cavalot, Franco, Frascaroli, Chiara, Guerrasio, Angelo, Russo, Isabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Schattauer GmbH 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291961/
https://www.ncbi.nlm.nih.gov/pubmed/28405672
http://dx.doi.org/10.1160/TH16-07-0586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291961/
https://www.ncbi.nlm.nih.gov/pubmed/28405672
http://dx.doi.org/10.1160/TH16-07-0586

Ejemplares similares